WallStSmart

Aveanna Healthcare Holdings Inc (AVAH)vsHCA Holdings Inc (HCA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Holdings Inc generates 3007% more annual revenue ($75.60B vs $2.43B). AVAH leads profitability with a 9.3% profit margin vs 9.0%. AVAH trades at a lower P/E of 6.3x. HCA earns a higher WallStSmart Score of 69/100 (B-).

AVAH

Buy

62

out of 100

Grade: C+

Growth: 8.7Profit: 7.5Value: 8.3Quality: 5.0

HCA

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVAHUndervalued (+83.8%)

Margin of Safety

+83.8%

Fair Value

$49.14

Current Price

$6.62

$42.52 discount

UndervaluedFair: $49.14Overvalued
HCAUndervalued (+59.9%)

Margin of Safety

+59.9%

Fair Value

$1326.31

Current Price

$484.02

$842.29 discount

UndervaluedFair: $1326.31Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVAH4 strengths · Avg: 9.5/10
P/E RatioValuation
6.3x10/10

Attractively priced relative to earnings

Return on EquityProfitability
61.6%10/10

Every $100 of equity generates 62 in profit

EPS GrowthGrowth
465.2%10/10

Earnings expanding 465.2% YoY

Revenue GrowthGrowth
27.4%8/10

Revenue surging 27.4% year-over-year

HCA5 strengths · Avg: 9.0/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-8.3310/10

Conservative balance sheet, low leverage

Market CapQuality
$108.62B9/10

Large-cap with strong market position

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
44.5%8/10

Earnings expanding 44.5% YoY

Areas to Watch

AVAH1 concerns · Avg: 3.0/10
Market CapQuality
$1.44B3/10

Smaller company, higher risk/reward

HCA1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AVAH

The strongest argument for AVAH centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 27.4% demonstrates continued momentum.

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bear Case : AVAH

The primary concerns for AVAH are Market Cap.

Bear Case : HCA

The primary concerns for HCA are Altman Z-Score.

Key Dynamics to Monitor

AVAH profiles as a growth stock while HCA is a value play — different risk/reward profiles.

AVAH carries more volatility with a beta of 2.08 — expect wider price swings.

AVAH is growing revenue faster at 27.4% — sustainability is the question.

HCA generates stronger free cash flow (870M), providing more financial flexibility.

Bottom Line

HCA scores higher overall (69/100 vs 62/100). AVAH offers better value entry with a 83.8% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aveanna Healthcare Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.

HCA Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?